• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

CNS Summit 2017 Abstracts of Poster Presentations
Conclusion: This novel technology discriminates and quantifies subtle differences in behavior and neurological impairments in subjects afflicted with neurological injury/disease. KINARM assessments can be incorporated into multi-center trials (e.g., monitoring stroke motor recovery: NCT02928393). Further studies will determine if KINARM Labs can demonstrate a clinical effect with fewer subjects over a shorter trial period. Disclosures/funding: Dr. Stephen Scott is the inventor of KINARM and CSO of BKIN Technologies.   Multiplexed mass spectrometry assay identifies neurodegeneration biomarkers in CSF Presenter: Chelsky...
Source: Innovations in Clinical Neuroscience - November 1, 2017 Category: Neuroscience Authors: ICNS Online Editor Tags: Assessment Tools biomarkers Cognition Current Issue Drug Development General Genetics Medical Issues Neurology Patient Assessment Psychopharmacology Scales Special Issues Supplements Trial Methodology clinical trials CNS Su Source Type: research

The potential impact of computed tomography coronary calcium score screening on patients with dyslipidemia
CONCLUSION: CAC scoring is associated with reduced risk of myocardial infarction and death in asymptomatic dyslipidemia patients and should be considered as a screening tool in these patients. The presumed mechanism for improved outcomes is that early identification of CAD results in earlier or more intensive treatment, reducing future cardiac event risk.PMID:37614860 | PMC:PMC10444005 | DOI:10.1080/08998280.2023.2239083
Source: Baylor University Medical Center Proceedings - August 24, 2023 Category: Universities & Medical Training Authors: Brittany Miles Bunnarin Theng Bright O Etumuse Atefeh Zeinoddini Arsalan Saleem Source Type: research

The relationship between hemodialysis mortality and the Chinese medical insurance type.
Conclusions: The medical insurance model was independently associated with HD patient survival, NCMS was associated with increased mortality among patients undergoing maintenance hemodialysis in China. PMID: 31478795 [PubMed - in process]
Source: Renal Failure - September 5, 2019 Category: Urology & Nephrology Tags: Ren Fail Source Type: research

Incidence and Mortality Associated with Cardiovascular Medication among Hypertensive COVID-19 Patients in South Korea
CONCLUSION: In South Korea, beta-blockers exhibited potential benefits in lowering the incidence of COVID-19 among hypertensive patients. Furthermore, CCBs may lower the hospital mortality rate among hypertensive COVID-19 patients. These findings were also applied to the general adult population, regardless of hypertension.PMID:34164954 | PMC:PMC8236350 | DOI:10.3349/ymj.2021.62.7.577
Source: Yonsei Medical Journal - June 24, 2021 Category: Universities & Medical Training Authors: Tak Kyu Oh Hyoung Won Cho Jung Won Suh In Ae Song Source Type: research

Pages: 1  2  3  4  5  6  7  8